Ophthalmic Pharmaceuticals
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
148
NCT06697522
Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children
Phase: Phase 3
Role: Lead Sponsor
Start: Jun 25, 2023
Completion: Mar 26, 2024
Loading map...